Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial.

Robert C WelshPayam DehghaniRenato LopesDaniel M WojdylaRonald AronsonChristopher B GrangerStephan WindeckerAmit N VoraDragos VinereanuSigrun HalvorsenAlexander ParkhomenkoRoxana MehranJohn H AlexanderShaun Goodman

Published in: Open heart (2022)

NCT02415400.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
type diabetes
randomized controlled trial
phase iii
patient reported outcomes
double blind